-

S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples

Poster Presented at AGBT 2022 General Meeting Demonstrates the NIC+ Improves the Efficiency and Reliability of Nuclei Isolations for Sub-20 mg Samples

LIVERMORE, Calif.--(BUSINESS WIRE)--S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2022 general meeting the launch of the NIC+ Small Sample Cartridge for nuclei isolations from solid tissue. When used with the Singulator 100 TM System, the NIC+ cartridges automate the processing of solid tissue samples into suspensions of single nuclei with high yields and from sub-20 mg samples for a wide range of single-cell biology and genomic analyses.

Researchers are often faced with the challenge of isolating nuclei from scarce, precious samples. Samples less than 20 mg are often too small in size for efficient and reliable processing by manual methods. To ensure that researchers can isolate nuclei from sub-20 mg samples with consistency, the NIC+ cartridge (P/N 100-215-389) was developed for the Singulator 100 platform. A series of experiments were conducted to establish the performance of the NIC+ cartridges with respect to nuclei yield and quality.

“We’ve demonstrated that the NIC+ cartridge yields more, higher quality nuclei than the standard nuclei isolation cartridges,” said Dr. Stevan Jovanovich, President and CEO of S2 Genomics.

The NIC+ Small Volume cartridges will begin shipping in July 2022.

About S2 Genomics, Inc.

S2 Genomics, founded in 2016, is a leading developer of laboratory automation solutions for processing solid tissues for life science applications. S2 Genomics’ technology platforms integrate advanced fluidics, optics, and biochemistry to produce automated sample preparation solutions for the next generation sequencing (NGS) and cell biology markets, enabling discovery and innovation in life science research, healthcare, and agriculture. For more information, visit https://s2genomics.com.

For Research Use Only. Not for use in diagnostic procedures.

S2 Genomics, the S2 Genomics logo, and Singulator are trademarks of S2 Genomics, Inc.

Read the full press release here: https://s2genomics.com/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples

NIC+ Product information can be found here: https://s2genomics.com/small-sample-cartridge/

For the technical note visit: https://s2genomics.com/tech-note-use-of-nic-with-the-singulator-100-for-sub-20mg-samples To request a download of our AGBT 2022 posters or view the abstracts visit: https://info.s2genomics.com/en-us/agbt-2022-posters

Contacts

Stevan Jovanovich
stevanj@s2genomics.com

S2 Genomics, Inc.


Release Summary
Today at AGBT 2022, S2 Genomics announces the launch of the NIC+ Small Sample Cartridge for nuclei isolations from sub-20 mg samples of solid tissue.
Release Versions

Contacts

Stevan Jovanovich
stevanj@s2genomics.com

Social Media Profiles
More News From S2 Genomics, Inc.

S2 Genomics Announces Distribution Agreement with Bonsailab to Serve Iberian Peninsula

LIVERMORE, Calif.--(BUSINESS WIRE)--S2 Genomics, Inc. today announced that it has entered into a distribution agreement with Bonsailab for the promotion, sales, and support of S2 Genomics’ Singulator™ 100 and 200 systems and associated products for single-cell genomics and cell biology applications in Spain and Portugal. “The Iberian Peninsula is experiencing rapid growth across all areas of single cell genomics and cell biology. We are very excited about the partnership between S2 Genomics and...

S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator™ 100 System with Proteigene in France

LIVERMORE, Calif.--(BUSINESS WIRE)--S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for life science applications, announced today that it has entered into a distribution agreement with Proteigene for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in France. This partnership focuses on expanding S2 Genomics’ Singulator™ 100 System product line t...

S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia

LIVERMORE, Calif.--(BUSINESS WIRE)--S2 Genomics, Inc. today announced that it has entered into a distribution agreement with Techtum Lab AB for the promotion, sales, and support of S2 Genomics’ Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in Norway, Finland, Denmark and Sweden. “The Nordic region is experiencing significant growth across all areas of single cell genomics and cell biology spurring demand for improved single-cell preparatio...
Back to Newsroom